Home      |      About Us      |      Projects      |      People      |      Startups      |      Video      |      Links      |      Contact Us

The Coulter Translational Research Partnership is a $20M program that funds cutting edge biomedical technologies with the purpose of improving clinical practice. The program is also dedicated to training serial innovators in translational research and commercialization. Support and financing is based on technical merit, clinical impact, strength of team, intellectual property, and likelihood for adoption.

Significant funding for the Coulter Translational Research Partnership was provided by the Wallace H. Coulter Foundation.


News & Events:

November 2015

UVA BME and Coulter Program Collaborate with Bio-Med Tech Girls

Coulter Investment Forum Coming in 2016

RIVANNA Commences Sales of Accuro™, Continues Discussions with Three Potential Corporate Partners

September 2015

Cell Surface Discovery May Lead to Major Breakthrough in Cancer Treatment

August 2015

Texas Cardiac Arrhythmia Institute at St. David's Medical Center First in US to Use EpiAccess™ System

HemoSonics Awarded $1M Phase II Grant from the US Air Force

June 2015

TypeZero Tech: More High Hopes for Closed Loop Commercialization

Accuro Handheld Ultrasound Needle Guidance System Cleared by FDA

HemoShear Expands Focus to Discovery of Therapeutics

January 2015

HemoShear Announces Collaboration with Pfizer Inc. To Help Identify and Predict Drug-Induced Vascular Injury for Early Stage Compounds

November 2014

EpiEP Inc. Receives FDA 510(k) Clearance for EpiAccess System

August 2014

BioCentury Newsletter: Emerging Company Profile on NeoAntigenics

June 2014

Innovative Alumni Aiming to Put Ultrasound in Docs' Pockets

May 2014

HemoShear Secures $8.7 Million in Private Equity Offering

April 2014

PsiKick's batteryless sensors poised for coming 'Internet of things'

March 2014

U.Va.-UofM-UW Start-Up Announces NEA Venture Funding to Accelerate Energy-Efficient Wireless Technology

January 2014

U.Va. Spinoff Neoantigenics Announces Collaboration with Pfizer, Investment from CIT to Develop Antibody-based Therapeutics For Cancer

UVA, Russian Experts Target Drug-Resistant TB

September 2013

HemoShear Advances Human Relevant Science to Predict New Drug Safety

November 2012

Rivanna Medical featured in Daily Progress

October 2012

HemoShear closes $4M funding round

September 2012

HemoShear closes $1 million dollar debt financing

July 2012

HemoSonics received $100,000 in funding from CIT

July 2012

HemoShear featured in Daily Progress news

December 2011

The Center for Innovative Technology (CIT) recently announced its grant awards for Fall 2011. Several Coulter funded start-up companies were awarded funds through the Commonwealth Commercialization Research Fund. More...

October 2011

FDA To Companion DX Developers: Pre-Trial Assay Validation is Key (pdf)

September 26

The UVA-Coulter Partnership co-hosted a conference with the FDA. The conference was focused on translational research and the FDA regulatory process and was titled Medical Device Technology Innovation Partnerships.

May 3, 2011

The Wallace H. Coulter Foundation Translational Research Partnership Award Creates a $20 Million U.Va. Endowment for Translational Research in Biomedical Innovation. Read more...

December 3, 2010

Twelve UVa-related biotechnology firms were awarded over $2.7 million in grants under the new Qualified Therapeutic Discovery Project Program. To read more, please visit UVa Today.

Coulter ROPe Funds

Coulter Partnership announces new and innovate source of funds to support faculty translational research. Coulter ROPE Funds (pdf)